Last week, Global Health Ltd, the company which operates hospitals under the brand Medanta, made a strong debut on the Indian stock exchanges. Its shares gained 19% on the listing day. At Thursday’s close of INR462.50 per share, the stock is around 38% up from its issue price of INR336. The company’s initial public offering (IPO) had also garnered good interest. It was oversubscribed 9.58 times. Reasonable valuations, healthy financials, and
Synopsis With an alarming rise in cancer diagnosis rate in India, especially among the younger cohort, timely screening and therapeutic intervention are the need of the hour. One small state has devised a unique health model for cancer management and success. Here’s how it can help ensure an improved disease-free survival. Cancer, as a lifestyle […]
A bird flies past the logo of Sun Pharma installed on the facade of its corporate office in Mumbai, India. Synopsis Dilip Shanghvi’s Sun Pharma made a bold move entering the specialty-drugs business which has started to pay it back. Now, the company is scouting acquisitions and augmenting its in-house R&D to enhance its specialty-drugs […]
As per a recent report in The Lancet, the incidence of prostate cancer is expected to double in India over the next few years. A crucial weapon in averting a severe health catastrophe will be early detection. But before addressing the issue of testing, there’s a knotty ribbon problem to be solved.